Cysteine-lowering Treatment With Mesna
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Cysteine-lowering Treatment With Mesna is a clinical trial[1].
Key Facts
- Cysteine-lowering Treatment With Mesna is in the country of Norway[2].
- Cysteine-lowering Treatment With Mesna's instance of is recorded as clinical trial[3].
- Cysteine-lowering Treatment With Mesna's start time is recorded as +2020-11-02T00:00:00Z[4].
- Cysteine-lowering Treatment With Mesna's end time is recorded as +2021-10-21T00:00:00Z[5].
- Cysteine-lowering Treatment With Mesna's main subject is recorded as overweight[6].
- Cysteine-lowering Treatment With Mesna's number of participants is recorded as {'unit': '1', 'amount': '+25'}[7].
- Cysteine-lowering Treatment With Mesna's title is recorded as Cysteine-lowering Treatment With Mesna Against Obesity: Phase I Dose-finding Study[8].
- Cysteine-lowering Treatment With Mesna's short name is recorded as CYLOB[9].
- Cysteine-lowering Treatment With Mesna's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[10].
- Cysteine-lowering Treatment With Mesna's ClinicalTrials.gov ID is recorded as NCT04449536[11].
- Cysteine-lowering Treatment With Mesna's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+55'}[12].
- Cysteine-lowering Treatment With Mesna's research intervention is recorded as mesna[13].
- Cysteine-lowering Treatment With Mesna's clinical trial phase is recorded as phase I clinical trial[14].
- Cysteine-lowering Treatment With Mesna's research subject recruitment status is recorded as completed[15].
- Cysteine-lowering Treatment With Mesna's study type is recorded as interventional study[16].